ERIN MARTIN: Open Payments
NPI 1932440260 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 83 payments from 19 companies in 2025. Trend: 2023 $2,108 · 2024 $1,659 · 2025 $1,759
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $467 |
| AstraZeneca Pharmaceuticals LP | 11 | $300 |
| Lilly USA, LLC | 9 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $117 |
| PFIZER INC. | 6 | $115 |
| Boston Scientific Corporation | 1 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $51 |
Products named: Rybelsus, FARXIGA, Ozempic, AIRSUPRA, XIFAXAN, Wegovy, MOUNJARO, Ranger.
Industry payments across TN — which companies pay providers there.
